HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 241-252 of 1,979
Drug study icon
CompletedNCT00545675

Abilify in Bipolarity for 24 Weeks Treatment Effectiveness

Official study title

Multi-center, Double-blind, Randomized, Comparative Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify and Depakote in 24-week Treatment of Mania in Patients With Bipolar Disorder Remitted After 6-week Treatment With Abilify and Depakote

This study has finished and is no longer accepting participants.

In Seoul
BipolarityMedication studyAges 18–65
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Drug study icon
CompletedNCT00545142

Abilify in Bipolarity for 6 Weeks Treatment Effectiveness

Official study title

Multi-center, Single Arm, Open Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of Abilify With Depakote in the 6-week Treatment of Acute Mania in Patients With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Seoul
BipolarityMedication studyAges 18–65
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Drug study icon
TerminatedNCT00063362

Combination Therapy for Bipolarity

Official study title

Combination Therapy in Bipolar Rapid Cycling

This study ended early.

Location not clearly listed
BipolarityMedication studyAges 16+
Countries
Sponsor
University Hospitals Cleveland Medical Center
Drug study icon
TerminatedNCT01824602

Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I

What is this study about?

Researchers are comparing Eslicarbazepine acetate 1800 mg, Eslicarbazepine acetate 1200 mg, Eslicarbazepine acetate 600 mg and placebo to find out how the approaches affect manic symptoms in people with bipolarity type I during a manic episode.

This study ended early.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Bial - Portela C S.A.
Drug study icon
CompletedNCT01822678

Eslicarbazepine Acetate (BIA 2-093) for manic episodes in bipolarity type I

What is this study about?

Researchers compared Eslicarbazepine Acetate and placebo to find out how the approaches affected manic symptoms in people with bipolarity type I during a manic episode.

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityMedication studyAges 18+
Countries
Sponsor
Bial - Portela C S.A.
Drug study icon
CompletedNCT00195767

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolarity in Children and Adolescents

Official study title

An Open-Label Long-Term Study to Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

This study has finished and is no longer accepting participants.

In North Chicago
BipolarityMedication studyAges 10–17
Countries
United States
Sponsor
Abbott

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.